Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pBluescript SKII+mIL7

Mouse IL-7 cDNA

Catalog number RDB01475
Resource name pBluescript SKII+mIL7
Alternative name Mouse IL7 cDNA
Clone info. Mouse IL7 cDNA.
Comment This clone contains a cDNA fragment corresponding to the 581nt to 1045nt of NM_008371.5. Known differences (at least) : A to T substitution at 739nt (Gly) ; T to C substitution at 742nt (Thr).
Vector backbone pBluescript II SK (+) (Plasmid)
Size of vector backbone 3.0 kb
Selectable markers Amp^r
Gene/insert name Mouse IL-7 cDNA
Depositor|Developer Hamada, Hirofumi |
Other clones in our bank
External Database
Mouse IL-7
          Reference sequence
            
           
          Remarks, protocol and/or map (gif) RDB01475.gif

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
          Ordering Please visit Information of Request for Distribution.[link] 
          Order form           [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          提供案内 (日本国内) [open/close]

          提供条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB01475 pBluescript SKII+mIL7 DNA solution Please contact us.

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          How to cite this biological resource

          Materials & Methods section:

          The pBluescript SKII+mIL7 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01475).

          Reference section:

          Further references such as user reports and related articles (go to bottom)

          References and tips

          Featured content

          QC test results

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB12743_A4Cpp1-2.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: REVERSE-2 (Pr0100)
          Region: T3 pro,insert,T7 pro
          Sequence file: RDB12743_A4Cpa.seq check
          >01475_12743_A4Cp_Reverse_2_B04_04.ab1
              1 NNNNNNNNNN NNNNNNCNNG CGCGNNNTTA ACCCTCNCTA AAGGGAACAA AAGCTGGAGC
             61 TCCACCGCGG TGGCGGCCGC TCTAGACCAT GTTCCATGTT TCTTTTAGAT ATATCTTTGG
            121 AATTCCTCCA CTGATCCTTG TTCTGCTGCC TGTCACATCA TCTGAGTGCC ACATTAAAGA
            181 CAAAGAAGGT AAAGCATATG AGAGTGTACT GATGATCAGC ATCGATGAAT TGGACAAAAT
            241 GACAGGTACC GATAGTAATT GCCCGAATAA TGAACCAAAC TTTTTTAGAA AACATGTATG
            301 TGATGATACA AAGGAAGCTG CTTTTCTAAA TCGTGCTGCT CGCAAGTTGA AGCAATTTCT
            361 TAAAATGAAT ATCAGTGAAG AATTCAATGT CCACTTACTA ACAGTATCAC AAGGCACACA
            421 AACACTGGTG AACTGCACAA GTAAGGAAGA AAAAAACGTA AAGGAACAGA AAAAGAATGA
            481 TGCATGTTTC CTAAAGAGAC TACTGAGAGA AATAAAAACT TGTTGGAATA AAATTTTGAA
            541 GGGCAGTATA TAAACAGGAT CCCCCGGGCT GCAGGAATTC GATATCAAGC TTATCGATAC
            601 CGTCGACCTC GAGGGGGGGC CCGGTACCCA ATTCGCCCTA TAGTGAGTCG TATTACGCGC
            661 GCTCACTGGC CGTCGTTTTA CAACGTCGTG ACTGGGAAAA CCCTGGCGTT ACCCAACTTA
            721 ATCGCCTTGC AGCACATCCC CCTTTCGCCA GCTGGCGTAA TAGCGAANAG GCCCGCACCG
            781 ATCGCCCTTC CCAACAGTTG CGCAGCCTGA ATGGCGAATG GGANGCGCCC TGTAGCGGCG
            841 CATTAAGCGC GGCGGGTGTG GTGGTTACGC GCAGCGNGNN CGCTACACTT GCCAGCGCCC
            901 NANCGCCCGC NCCTTTCGCT TTCTNCCCNN CCTTTCNCGC CACGTNCGCC GGCTTTCCCN
            961 NNNNNGCNCT AAATCNGGGG NNNNCNNTTA NGNNNNCNNN TTNNNGCTTN ANNNNNNCNN
          1021 NNNNCNNNAA AANNNNNNNN NN
          //

          Please visit Sequencing and PCR primers for primer information.

          References

          Original, user report and related articles

          2023.05.01

          GNP_filter3_RDBDEP_html_230501.pl